Showing results (1621-1630 of 5,501) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|July 29, 2009
Assessment of appropriateness of indications for CT enterography in younger patientsLuís S Guimarães, Jeff L Fidler, Joel G Fletcher, et al.
Inflammatory Bowel Diseases|July 29, 2009
Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomyMatt W Johnson, Geraint B Rogers, Kenneth D Bruce, et al.
Inflammatory Bowel Diseases|July 29, 2009
Importance of mucosal healing in ulcerative colitisGary R Lichtenstein, Paul Rutgeerts
Inflammatory Bowel Diseases|July 30, 2009
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseC Reiff, M Delday, G Rucklidge, et al.
Inflammatory Bowel Diseases|August 29, 2009
Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancerStephan Brackmann, Geir Aamodt, Solveig Norheim Andersen, et al.
Inflammatory Bowel Diseases|August 29, 2009
A new tool to measure the burden of Crohn's disease and its treatment: do patient and physician perceptions match?Allison R Wilcox, Maria Concepcion C Dragnev, Christopher J Darcey, et al.
Inflammatory Bowel Diseases|August 29, 2009
Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependentAlip Borthakur, Sumit Bhattacharyya, Waddah A Alrefai, et al.
Inflammatory Bowel Diseases|August 29, 2009
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitisDaniel C Baumgart, Stephan R Targan, Axel U Dignass, et al.
Inflammatory Bowel Diseases|August 29, 2009
Course of inflammatory bowel disease in patients infected with human immunodeficiency virusNikos Viazis, John Vlachogiannakos, Ourania Georgiou, et al.
Inflammatory Bowel Diseases|August 26, 2009
Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitisLiliana Andrade Chebli, Leonardo Duque de Miranda Chaves, Felipe Ferreira Pimentel, et al.
Pageof 551